Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 15, 2026
Reporting period
Not applicable
Filed with the SEC
May 20, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001628280-26-036627
Filed / recorded
May 20, 2026, 2:28 AM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Marvell Technology, Inc.
Issuer CIK
1835632
Ticker
MRVL
Reporting person
Chris Koopmans
Relationship
Officer
Officer title
President and COO
Security
Performance Stock Units
Table
Derivative (Table II)
Transaction date
May 15, 2026
Transaction code
M
Shares / units
56,232
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
78,098
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each performance stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting.
This performance stock unit award included stock price and total stockholder return-based performance criteria and was structured in four tranches tied to stock price targets of $60, $80, $100, and $120, with a TSR modifier applicable to the award. The performance conditions for the $60 tranche, the $80 tranche, and the $100 tranche were certified on August 22, 2023, December 5, 2024, and January 24, 2025, respectively. As a result, the three certified tranches became subject to a service-based vesting condition pursuant to which 50% of the shares vested on May 15, 2026 and 50% of the shares will vest on May 15, 2028 (subject to continued service to the company). The performance criteria for the remaining tranche tied to the $120 stock price target have not yet been certified.
